HOG
29
4
CLX
65
2
FTI
61
5
EXPD
29
2
VNO
46
6
M
40
3
JWN
72
9
DIS
70
2
NKE
36
2
PWR
63
3
CAG
34
3
PX
56
3
ROST
60
3
NWSA
69
4
LRCX
56
4
PYPL
49
4
EQIX
59
2
MAT
41
2
BF.B
35
2
TMO
52
8
HOG
29
4
CLX
65
2
FTI
61
5
EXPD
29
2
VNO
46
6
M
40
3
JWN
72
9
DIS
70
2
NKE
36
2
PWR
63
3
CAG
34
3
PX
56
3
ROST
60
3
NWSA
69
4
LRCX
56
4
PYPL
49
4
EQIX
59
2
MAT
41
2
BF.B
35
2
TMO
52
8
Financhill
Back

Greenlight Capital Re Vs. Novo Nordisk AS Industry Stock Comparison

Buy
60

GLRE
Greenlight Capital Re

Last Price:
$13.84
Seasonality Move:
2.45%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Buy
60
Greenlight Capital Re (GLRE) is a Buy

Is Greenlight Capital Re a Buy, Sell or Hold?

  • The current Greenlight Capital Re [GLRE] share price is $13.90. The Score for GLRE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • GLRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GLRE Stock Price Chart

What is Greenlight Capital Re's stock price today?

  • The Greenlight Capital Re share price today is $13.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLRE is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

GLRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 30.72 Sell
Chaikin Money Flow: 48947 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.37 - 15.09) Sell
Bollinger Bands (100): (13.22 - 14.62) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

GLRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.39 Sell
20-day SMA: 14.74 Sell
50-day SMA: 14.33 Sell
200-day SMA: 13.3 Buy
8-day EMA: 14.28 Sell
20-day EMA: 14.52 Sell
50-day EMA: 14.37 Sell
200-day EMA: 13.34 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Greenlight Capital Re Earnings Growth & GLRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Greenlight Capital Re Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):